Oosterwijk J C, Jansen J C, van Schothorst E M, Oosterhof A W, Devilee P, Bakker E, Zoeteweij M W, van der Mey A G
Department of Clinical Genetics, Leiden University Hospital, The Netherlands.
J Med Genet. 1996 May;33(5):379-83. doi: 10.1136/jmg.33.5.379.
Hereditary glomus tumour (MIM 168,000) or paraganglioma (PGL) is a slowly progressive disorder causing benign tumour growth predominantly in the head and neck region. Though benign in nature the tumours can lead to severe morbidity. Inheritance of PGL is autosomal dominant and is strongly modified by genomic imprinting; only a paternally transmitted PGL gene leads to symptoms. A gene for PGL has recently been mapped to 11q22.3-q23. Genetic counselling on the basis of DNA linkage diagnosis was offered in an extended Dutch pedigree. Thirty-two subjects opted for further counselling, of whom 20 applied for DNA testing and participated in a standardised protocol. Sixteen cases had presymptomatic testing (paternal allele); four of these appeared to have the at risk haplotype and in two of them a glomus tumour was subsequently detected on MRI. In one case linkage results were inconclusive (recombination) and one person did not want to learn his test result. Four cases had testing for carrier status (maternal allele) of which one appeared to be a carrier. Our data show that genetic counselling gains significant accuracy when based on parent of origin, sex of the counsellee, and DNA linkage diagnosis. Moreover, a normal DNA result may prevent unnecessary worry and investigations, while an established presymptomatic diagnosis will guide adequate clinical management. The psychological impact of counselling and predictive DNA testing is unclear as yet. Further investigations into the natural history of PGL in gene carriers and into the psychological impact of DNA testing is desirable.
遗传性血管球瘤(MIM 168,000)或副神经节瘤(PGL)是一种进展缓慢的疾病,主要导致头颈部区域的良性肿瘤生长。虽然本质上是良性的,但这些肿瘤可导致严重的发病情况。PGL的遗传方式为常染色体显性遗传,并受到基因组印记的强烈影响;只有父系传递的PGL基因才会导致症状。最近已将一个PGL基因定位到11q22.3 - q23。在一个荷兰大家庭谱系中提供了基于DNA连锁诊断的遗传咨询。32名受试者选择进一步咨询,其中20人申请了DNA检测并参与了标准化方案。16例进行了症状前检测(父系等位基因);其中4例似乎具有风险单倍型,其中2例随后在MRI上检测到血管球瘤。1例连锁结果不明确(重组),1人不想知道检测结果。4例进行了携带者状态检测(母系等位基因),其中1例似乎是携带者。我们的数据表明,基于起源父母、受咨询者性别和DNA连锁诊断的遗传咨询具有显著更高的准确性。此外,正常的DNA结果可避免不必要的担忧和检查,而确诊的症状前诊断将指导适当的临床管理。目前尚不清楚咨询和预测性DNA检测的心理影响。对基因携带者中PGL的自然病史以及DNA检测的心理影响进行进一步研究是很有必要的。